Coherus Oncology, Inc. (CHRS) › Shares OutstandingCoherus Oncology, Inc. (CHRS) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2013: 4.84M2014: 33.26M2015: 39.01M2016: 45.81M2017: 59.84M2018: 68.30M2019: 70.37M2020: 72.51M2021: 76.93M2022: 78.85M2023: 112.22M2024: 115.61M2025: 121.15M121.15M2013Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025121.15M+4.8%2024115.61M+3.0%2023112.22M+42.3%202278.85M+2.5%202176.93M+6.1%202072.51M+3.1%201970.37M+3.0%201868.30M+14.1%201759.84M+30.6%201645.81M+17.4%201539.01M+17.3%201433.26M+587.5%20134.84M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share